Teva Pharmaceutical (TEVA): The Global Leader in Affordable Medicine Under $25
Goldman's Hedge Fund VIP List: AMZN, VST, CRM, BABA, and More
Unusual Options Activity: TEVA, MDT and Others Attract Market Bets, TEVA V/OI Ratio Reaches 322.6
EST Nov 18th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Teva Pharmaceutical Industries (NYSE:TEVA) Shareholders Are Still up 85% Over 3 Years Despite Pulling Back 4.0% in the Past Week
US Manufacturing Index Rises To 43, Highest Since 2020
Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids